These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15048793)

  • 1. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation.
    Staatz CE; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2004 Apr; 10(4):506-12. PubMed ID: 15048793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients.
    Dansirikul C; Staatz CE; Duffull SB; Taylor PJ; Lynch SV; Tett SE
    J Clin Pharm Ther; 2006 Feb; 31(1):17-25. PubMed ID: 16476116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
    Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
    Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.
    Capron A; Lerut J; Verbaandert C; Mathys J; Ciccarelli O; Vanbinst R; Roggen F; De Reyck C; Lemaire J; Wallemacq PE
    Ther Drug Monit; 2007 Jun; 29(3):340-8. PubMed ID: 17529892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
    Blanchet B; Duvoux C; Costentin CE; Barrault C; Ghaleh B; Salvat A; Jouault H; Astier A; Tod M; Hulin A
    Ther Drug Monit; 2008 Aug; 30(4):412-8. PubMed ID: 18641556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.
    Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ
    J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy.
    Schulz-Juergensen S; Burdelski MM; Oellerich M; Brandhorst G
    Ther Drug Monit; 2012 Feb; 34(1):4-10. PubMed ID: 22210096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients.
    Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C
    Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation.
    Goto M; Masuda S; Kiuchi T; Ogura Y; Oike F; Tanaka K; Uemoto S; Inui K
    J Pharmacol Exp Ther; 2008 May; 325(2):610-6. PubMed ID: 18252812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay.
    Borrows R; Chusney G; Loucaidou M; Singh S; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Transplant Proc; 2005 May; 37(4):1733-5. PubMed ID: 15919448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus.
    Casas-Melley AT; Falkenstein KP; Flynn LM; Ziegler VL; Dunn SP
    Pediatr Transplant; 2004 Aug; 8(4):362-6. PubMed ID: 15265163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.
    Venkat VL; Nick TG; Wang Y; Bucuvalas JC
    Pediatr Transplant; 2008 Feb; 12(1):67-72. PubMed ID: 18186891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buccal vs. nasogastric tube administration of tacrolimus after pediatric liver transplantation.
    Goorhuis JF; Scheenstra R; Peeters PM; Albers MJ
    Pediatr Transplant; 2006 Feb; 10(1):74-7. PubMed ID: 16499591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients.
    Taber DJ; Dupuis RE; Fann AL; Andreoni KA; Gerber DA; Fair JH; Johnson MW; Shrestha R
    Liver Transpl; 2002 Mar; 8(3):219-23. PubMed ID: 11910566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved pharmacokinetic monitoring of tacrolimus exposure after pediatric renal transplantation.
    Lee MN; Butani L
    Pediatr Transplant; 2007 Jun; 11(4):388-93. PubMed ID: 17493218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.